6:25 PM
 | 
Dec 12, 2012
 |  BC Extra  |  Financial News

Infinity, Sarepta planning follow-ons

Infinity Pharmaceuticals Inc. (NASDAQ:INFI) and Sarepta Therapeutics Inc. (NASDAQ:SRPT) both proposed follow-ons late Wednesday. Infinity's follow-on is underwritten by Morgan Stanley; JPMorgan; BofA Merrill Lynch; Deutsche Bank; and...

Read the full 130 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >